Dr. Stephen J. Savage
Claim this profileRalph H Johnson VA Medical Center
Studies Prostate Cancer
Studies Bladder Cancer
7 reported clinical trials
10 drugs studied
Area of expertise
1Prostate Cancer
Stage I
Stage II
Stage IV
2Bladder Cancer
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Stephen J. Savage is currently running
ONCOFID-P-B
for Bladder Cancer
This trial tests ONCOFID-P-B, a bladder-inserted medication, in adults with certain types of bladder cancer who did not respond to standard treatment and cannot or do not want surgery. The treatment aims to directly target and kill cancer cells in the bladder. ONCOFID-P-B is a new compound developed by Fidia Farmaceutici S.p.A. with specific binding to the CD44 receptor, showing high safety and effectiveness in patients with bladder cancer that did not respond to previous treatments.
Recruiting2 awards Phase 314 criteria
Pembrolizumab + Gemcitabine
for Bladder Cancer
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding pembrolizumab to gemcitabine may delay the return of BCG-unresponsive bladder cancer for longer period compared to gemcitabine alone.
Recruiting1 award Phase 223 criteria
More about Stephen J. Savage
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Stephen J. Savage has experience with
- ProstAtak® Immunotherapy
- ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
- Simvastatin
- Pembrolizumab
- Gemcitabine Hydrochloride
- Green Tea
Breakdown of trials Stephen J. Savage has run
Prostate Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen J. Savage specialize in?
Stephen J. Savage focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage I patients, or patients who are Stage II.
Is Stephen J. Savage currently recruiting for clinical trials?
Yes, Stephen J. Savage is currently recruiting for 5 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Stephen J. Savage has studied deeply?
Yes, Stephen J. Savage has studied treatments such as ProstAtak® Immunotherapy, ONCOFID P-B (PACLITAXEL-HYALURONIC ACID), Simvastatin.
What is the best way to schedule an appointment with Stephen J. Savage?
Apply for one of the trials that Stephen J. Savage is conducting.
What is the office address of Stephen J. Savage?
The office of Stephen J. Savage is located at: Ralph H Johnson VA Medical Center, Charleston, South Carolina 29401 United States. This is the address for their practice at the Ralph H Johnson VA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.